Exelixis
EXEL
#1855
Rank
A$15.98 B
Marketcap
A$59.39
Share price
-2.18%
Change (1 day)
10.08%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

Exelixis (EXEL) Fails to deliver data

Key failure to deliver metrics for Exelixis:

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Exelixis (EXEL) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Exelixis (EXEL) - since 2013

Volume in USD (price x number of shares), data since 2013

Exelixis (EXEL) Failure to deliver volume, Year over Year

Year Volume (Price x Shares) Change
2026A$3.19 M-87.13%
2025A$24.8 M105.32%
2024A$12.08 M86.29%
2023A$6.48 M-41.81%
2022A$11.14 M-31.9%
2021A$16.36 M-20.71%
2020A$20.64 M303.63%
2019A$5.11 M-70.5%
2018A$17.33 M8.82%
2017A$15.92 M-17.35%
2016A$19.27 M-75.68%
2015A$79.23 M19.37%
2014A$66.37 M258.49%
2013A$18.51 M

FTD volume in the last 3 months for similar companies or competitors

Company FTD volume (3 months) FTD volume (1 year) Country
Johnson & Johnson
JNJ
A$24.94 MA$0.10 B๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
A$56.21 MA$0.12 B๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
A$0.20 BA$0.37 B๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
A$10.89 MA$69.64 M๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
A$36.21 MA$0.14 B๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$31.05 MA$81.93 M๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
A$48.95 MA$0.36 B๐Ÿ‡ฌ๐Ÿ‡ง UK
Curis
CRIS
A$0.23 MA$1.17 M๐Ÿ‡บ๐Ÿ‡ธ USA
AVEO Oncology
AVEO
N/AA$0.04 M๐Ÿ‡บ๐Ÿ‡ธ USA